ArticleNature biomedical engineering2018

Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning.

Michael S Manak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.